Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients

BACKGROUND: To evaluate resource use and health costs due to the combination of metformin and dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with diabetes and renal impairment in routine clinical practice. METHODS: An observational, retrospective study was performed. Patients aged ≥30 years t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sicras-Mainar, Antoni, Navarro-Artieda, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342540/
https://www.ncbi.nlm.nih.gov/pubmed/25729716
http://dx.doi.org/10.4093/dmj.2015.39.1.74

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342540/
https://www.ncbi.nlm.nih.gov/pubmed/25729716
http://dx.doi.org/10.4093/dmj.2015.39.1.74

Ejemplares similares